In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes

Objective: Short peptides play a significant role in exploring drugs with higher selectivity and fewer side effects in cancer and COVID-19 therapies. This study evaluated the anticancer and anti-COVID-19 activities of Glu-Arg-Gln (ERQ) tripeptide for the first time. To discover the potentiality of t...

Full description

Saved in:
Bibliographic Details
Main Authors: Gözde Yılmaz, Sefa Çelik, Ayşen Erbölükbaş Özel, Sevim Akyüz
Format: Article
Language:English
Published: Istanbul University Press 2024-05-01
Series:European Journal of Biology
Subjects:
Online Access:https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/54C2735EA00B4478898934BA24EF6AC2
Tags: Add Tag
No Tags, Be the first to tag this record!